McDowell, A., Jr.; Hill, K.S.; McCorkle, J.R.; Gorski, J.; Zhang, Y.; Salahudeen, A.A.; Ueland, F.; Kolesar, J.M.
Preclinical Evaluation of Artesunate as an Antineoplastic Agent in Ovarian Cancer Treatment. Diagnostics 2021, 11, 395.
https://doi.org/10.3390/diagnostics11030395
AMA Style
McDowell A Jr., Hill KS, McCorkle JR, Gorski J, Zhang Y, Salahudeen AA, Ueland F, Kolesar JM.
Preclinical Evaluation of Artesunate as an Antineoplastic Agent in Ovarian Cancer Treatment. Diagnostics. 2021; 11(3):395.
https://doi.org/10.3390/diagnostics11030395
Chicago/Turabian Style
McDowell, Anthony, Jr., Kristen S. Hill, Joseph Robert McCorkle, Justin Gorski, Yilin Zhang, Ameen A. Salahudeen, Fred Ueland, and Jill M. Kolesar.
2021. "Preclinical Evaluation of Artesunate as an Antineoplastic Agent in Ovarian Cancer Treatment" Diagnostics 11, no. 3: 395.
https://doi.org/10.3390/diagnostics11030395
APA Style
McDowell, A., Jr., Hill, K. S., McCorkle, J. R., Gorski, J., Zhang, Y., Salahudeen, A. A., Ueland, F., & Kolesar, J. M.
(2021). Preclinical Evaluation of Artesunate as an Antineoplastic Agent in Ovarian Cancer Treatment. Diagnostics, 11(3), 395.
https://doi.org/10.3390/diagnostics11030395